Sangamo Therapeutics raises ~$23M in underwritten public offering of common stock and warrants

SANGAMO THERAPEUTICS, INC

Offering of 12.2M shares and pre-funded warrants for 34.4M shares, each with accompanying purchase warrant, at $0.50 unit price.
Gross proceeds expected ~$23M, before underwriting discounts and expenses; closing expected May 14, 2025.
Pre-funded warrants exercisable at $0.01 per share; purchase warrants at $0.75 per share, exercisable after six months for six years.
Sangamo may force exercise of purchase warrants if stock price exceeds $2.75 for ten consecutive trading days after six months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.